China Health Industries Holdings Inc - Stock Quote CHHE
Morningstar's China Health Industries Holdings Inc Stock Analysis
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible for overseeing the methodology that supports the quantitative fair value. As an employee of Morningstar, Inc., Mr. Davidson is guided by Morningstar, Inc.'s Code of Ethics and Personal Securities Trading Policy in carrying out his responsibilities. For information regarding Conflicts of Interests, click here .
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
China Health Industries Holdings Inc's Company Profile
China Health Industries Holdings Inc operates in the health product industry. It is engaged in the manufacturing, marketing, and distribution of health food products. The company segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment. HLJ Huimeijia business segment engages in the manufacture and distribution of tincture, ointments, rubber paste, topical solution, suppositories, liniment, enemas, and oral liquids.
Harbin, 150028, China, People's Republic of